MRSH

MRSH remains in a clear Stage 2 advancing regime with persistent higher highs and higher lows and active Momentum Breakout and Lockout Rally dynamics driving aggressive demand. While price is extended well above rising 9/21 EMAs and in extreme overbought territory, the Lockout Rally override supports immediate participation. Buying now in the breakout region aligns with continuation, using the 9/21 EMA zone as a reference for pullback interaction.

• ↑Q1 revenue rose 8% YoY to $7.6 B, driven by double-digit consulting growth
• ↑Executed $750 M buybacks and plans $5 B capital deployment this year
• ↓Primary insurance rates fell 5% in Q1, squeezing top-line growth